Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration

News May 09, 2007

Thrombotargets Corp and Instituto Biomar have announced the signature of a drug discovery collaboration agreement.

Under the terms of this agreement, Instituto Biomar will provide Thrombotargets Corp with its libraries of purified natural products and extracts collection for its High Throughput Screening of Pathway Activity (HTS-PA) in Thrombotargets’ technology.

Thrombotargets will seek to identify and optimize drug candidates for multiple targets that will be jointly developed by both companies.

Arming Drug Hunters: Chemists design new reaction for drug discovery

News

The pair of Colorado State University organic chemists have forged a powerful new tool for drug hunters - a simple, elegantly designed chemical reaction that could fling open an underexplored wing of biologically relevant chemistry.

Drug Candidate Could Recover Vocal Abilities Lost to ADNP Syndrome

News

A new Tel Aviv University study finds that the drug candidate CP201, also known as NAP, may improve vocal communication abilities that are underdeveloped in Activity-dependent neuroprotective protein (ADNP) patients.

New Inflammation Inhibitor Discovered

News

A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action.

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free